Cardiovascular disease, or CVD, remains one of our biggest killers. And elevated cholesterol is one of CVD’s most influential biomarkers. Twenty-five percent of Americans over 40 take one of these medications, costing $20 billion annually. Are we getting any worthwhile bang for the buck?
Those with elevated cholesterol frequently have identical risk factors for developing Type 2 diabetes. Statins are known to increase the incidence of diabetes. But is this a result of confounding or a separate concern? A new study tries to untie this Gordian knot of confounders.